The Global Transcatheter Aortic Valve Replacement Devices Market to Register Growth at a Tremendous CAGR of 15.41% by 2027, Assesses DelveInsight

New York, USA, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The Global Transcatheter Aortic Valve Replacement Devices Market to Register Growth at a Tremendous CAGR of 15.41% by 2027, Assesses DelveInsight

As per Delveinsight analysis in the transcatheter aortic valve replacement devices market, the increasing prevalence of aortic stenosis disorder, the rising demand for transcatheter aortic valve replacement (TAVR) procedures and technological advancements in the transcatheter aortic valve replacement arena are likely to propel the global transcatheter aortic valve replacement devices market.

DelveInsight’s Transcatheter Aortic Valve Replacement Devices Market Insights report provides the current and forecast market analysis, individual leading transcatheter aortic valve replacement devices companies’ market shares, challenges, transcatheter aortic valve replacement devices market drivers, barriers, and trends, and key transcatheter aortic valve replacement devices companies in the market.

Key Takeaways from the Transcatheter Aortic Valve Replacement Devices Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global transcatheter aortic valve replacement devices market during the forecast period. 
• Notable transcatheter aortic valve replacement devices companies such as Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Meril Life Sciences, Abbott, JenaValve Technology, Inc., Bracco SpA, Transcatheter Technologies GmbH, Braile Biomedica, Venus Medtech, Direct Flow Medical, Sorin group, Blue Sail Medical Co. Ltd., JC Medical Inc.,  Cook Medical Inc., Sysmetis SA, SMT Pvt Ltd., LivaNova, Peijia Medical, and P+F Products + Features GmbH, and several others are currently operating in the transcatheter aortic valve replacement devices market.
• On September 15, 2022, OpSens Inc. announced that the FDA had granted 510(k) regulatory clearance for the SavvyWire, its new guidewire for transcatheter aortic valve replacement (TAVR) procedures.
• In September 2022, Edwards Lifesciences received FDA approval for the latest generation of its Sapien 3 transcatheter aortic valve, which is outfitted with materials that the company claims will form the foundation of future heart valve implants.
• On September 20, 2021, Abbott announced the Food and Drug Administration (FDA) for the company's Portico™ with FlexNav™ transcatheter aortic valve replacement (TAVR) system to treat people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery.
• On August 24, 2021, Medtronic plc announced the U.S. Food and Drug Administration (FDA) approval of its newest-generation, self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut™ FX TAVR system.
• On May 17, 2021, Abbott announced that it had received CE Mark for its latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor™, making the minimally invasive device available for people in Europe with severe aortic stenosis who are at high or extreme surgical risk.
• Thus, owing to such developments in the market, rapid growth will be observed in the transcatheter aortic valve replacement devices market during the given forecast period.

To read more about the latest highlights related to the transcatheter aortic valve replacement devices market, get a snapshot of the key highlights entailed in the Global Transcatheter Aortic Valve Replacement Devices Market Report

Transcatheter Aortic Valve Replacement Devices Overview

Aortic stenosis is a condition in which an aortic valve does not fully open, causing blood flow to be restricted. An aorta is a large artery that transports blood from the heart to the rest of the body. These high-risk patients are those who are inoperable and cannot undergo the surgical aortic valve replacement (SAVR) procedure.

Transcatheter aortic valve replacement is a procedure wherein an artificial, man-made valve replaces the diseased valve. Transcatheter heart valves are made of biological tissues and are surrounded by a steel, cobalt-chromium, or nitonol stent. These valves can be balloon expandable or self-expanding. Several man-made transcatheter aortic valves are used while performing TAVR procedures. These include SAPIEN 3, SAPIEN 3 Ultra, Evolut PRO+, and LOTUS Edge.

Transcatheter Aortic Valve Replacement Devices Market Insights 

The global transcatheter aortic valve replacement devices market is being studied geographically for North America, Europe, Asia-Pacific, and the Rest of the World. North America currently leads the global transcatheter aortic valve replacement devices market in terms of revenue share and is expected to maintain this position throughout the study period. This can be attributed to the rising number of aortic stenosis and aortic regurgitation cases, the rising prevalence of cardiovascular diseases, the rise in transcatheter aortic valve replacement device approvals and launches, and their expansion in newer indications, which are the key factors contributing to the transcatheter aortic valve replacement devices market, which is expected to aid in the growth of the North American transcatheter aortic valve replacement devices market.

To know more about why North America is leading the market growth in the transcatheter aortic valve replacement devices market, get a snapshot of the Transcatheter Aortic Valve Replacement Devices Market Outlook

The global transcatheter aortic valve replacement devices market is expected to grow significantly due to the increasing prevalence of aortic stenosis disorder, rise in cardiovascular disorders, increasing demand for TAVR procedures, increasing prevalence of aortic regurgitation, and technological advancements in the transcatheter aortic valve replacement arena, all of which are expected to increase product demand, thereby contributing to the transcatheter aortic valve replacement devices market

However, the stringent regulatory approval process for transcatheter aortic valves and the high costs associated with TAVR procedures may prove to be impediments to the growth of the transcatheter aortic valve replacement devices market.

Furthermore, the unprecedented COVID-19 pandemic has slowed the transcatheter aortic valve replacement devices market during the pandemic, with lockdown restrictions in many countries where surgeries were only performed on an emergency and urgent basis because most healthcare resources were used to combat the COVID-19 situation. This resulted in a decrease in the overall number of surgeries performed, including the transcatheter aortic valve replacement devices market. However, with the mass vaccination of the population and the resumption of activities, including in the healthcare sector, the transcatheter aortic valve replacement devices market has gained traction and is expected to grow significantly during the forecast period.

Get a sneak peek at the transcatheter aortic valve replacement devices market dynamics @ Transcatheter Aortic Valve Replacement Devices Market Dynamics Analysis

Transcatheter Aortic Valve Replacement Devices Market Assessment

• Transcatheter Aortic Valve Replacement Devices Market Segmentation
  • Market Segmentation By Technology Type: Valve Frame Material (Nitinol, Stainless Steel, Cobalt Chromium and Others), Valve Leaflet Material (Porcine, Bovine and Others)
  • Market Segmentation By Procedure: Transfemoral, Transapical and Transaortic Approach
  • Market Segmentation By Application: Aortic Stenosis, Aortic Regurgitation and Others
  • Market Segmentation By End User: Hospitals, Ambulatory Surgical Centers, and Others
  • Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the transcatheter aortic valve replacement devices market are set to emerge as the trendsetter explore @ Transcatheter Aortic Valve Replacement Devices Companies 

Table of Contents 

Interested in knowing the transcatheter aortic valve replacement devices market by 2027? Click to get a snapshot of the Transcatheter Aortic Valve Replacement Devices Market Trends

Related Reports

Abdominal Aortic Aneurysm Market

Abdominal Aortic Aneurysm Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key abdominal aortic aneurysm companies, including Endologix LLC, Cardinal Health, Cook Medical, W. L. Gore & Associates, Inc., Medtronic, MicroPort Scientific Corporation, among others.

Abdominal Aortic Aneurysm Epidemiology

Abdominal Aortic Aneurysm Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical, and forecasted abdominal aortic aneurysm epidemiology in the 7MM.

Abdominal Aortic Aneurysm Pipeline

Abdominal Aortic Aneurysm Pipeline Insight – 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key abdominal aortic aneurysm companies, including Faron Pharmaceuticals, Novartis, AstraZeneca, among others.

Abdominal Aneurysm Pipeline

Abdominal Aneurysm Pipeline Insight – 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key abdominal aneurysm companies, including Faron Pharmaceuticals, Novartis, AstraZeneca, among others.

Abdominal Aneurysm Epidemiology

Abdominal Aneurysm Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical, and forecasted abdominal aneurysm epidemiology in the 7MM.

Complicated Intra-Abdominal Infections Market

Complicated Intra-Abdominal Infections Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key complicated intra-abdominal infections companies, including MerLion Pharmaceuticals, AiCuris, Novartis, among others.

Complicated Intra-Abdominal Infections Pipeline

Complicated Intra-Abdominal Infections Pipeline Insight – 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key complicated intra-abdominal infections companies, including Pfizer, Shionogi, Iterum Therapeutics, Nosopharm, among others.

Other Trending Reports

Related Healthcare Blogs

Upcoming Cardiovascular Diseases Drugs

Key Companies in the Cardiology Segment

Heart Failure Market

Top Cardiac Devices in the Market

Related Healthcare Services

Healthcare Business Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.